Financhill
Sell
37

MTD Quote, Financials, Valuation and Earnings

Last price:
$1,174.65
Seasonality move :
4.58%
Day range:
$1,139.44 - $1,175.51
52-week range:
$1,136.00 - $1,546.93
Dividend yield:
0%
P/E ratio:
28.93x
P/S ratio:
6.45x
P/B ratio:
--
Volume:
131.7K
Avg. volume:
136.2K
1-year change:
-11.24%
Market cap:
$24.5B
Revenue:
$3.9B
EPS (TTM):
$40.53

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
MTD
Mettler-Toledo International
$876.6M $7.90 -5.42% -4.25% $1,360.80
CTSO
CytoSorbents
$10.8M -$0.07 12.22% -41.38% $5.00
DCTH
Delcath Systems
$16.8M $0.03 436.11% -93.78% $22.50
DGX
Quest Diagnostics
$2.6B $2.16 11.25% 25.48% $177.10
STRR
Star Equity Holdings
$16.4M -$0.25 79.32% -70.59% $10.00
WAT
Waters
$655.5M $2.23 2.93% 29.58% $404.35
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
MTD
Mettler-Toledo International
$1,172.50 $1,360.80 $24.5B 28.93x $0.00 0% 6.45x
CTSO
CytoSorbents
$1.00 $5.00 $55M -- $0.00 0% 1.56x
DCTH
Delcath Systems
$12.98 $22.50 $433.6M -- $0.00 0% 10.26x
DGX
Quest Diagnostics
$167.96 $177.10 $18.6B 21.84x $0.75 1.79% 1.93x
STRR
Star Equity Holdings
$2.36 $10.00 $7.6M 0.75x $0.00 0% 0.14x
WAT
Waters
$356.00 $404.35 $21.2B 33.24x $0.00 0% 7.17x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
MTD
Mettler-Toledo International
106.72% 1.360 7.86% 0.64x
CTSO
CytoSorbents
51.51% 1.605 16.8% 1.46x
DCTH
Delcath Systems
-- 2.377 -- 10.46x
DGX
Quest Diagnostics
48.48% 0.464 38.46% 0.85x
STRR
Star Equity Holdings
17.24% -0.529 43.09% 1.26x
WAT
Waters
47.08% 1.648 7.38% 1.34x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
MTD
Mettler-Toledo International
$639.3M $333.7M 45.08% -- 31.81% $224.9M
CTSO
CytoSorbents
$4.5M -$4.4M -70.49% -103.21% -20.27% -$2.8M
DCTH
Delcath Systems
$13M $3M -97.08% -117.89% 68.93% -$1.2M
DGX
Quest Diagnostics
$858M $361M 7.24% 12.99% 14.16% $341M
STRR
Star Equity Holdings
$4.4M $3.6M -15.36% -17.45% 20.95% -$3.9M
WAT
Waters
$524.2M $292.3M 18.63% 43.99% 33.92% $188M

Mettler-Toledo International vs. Competitors

  • Which has Higher Returns MTD or CTSO?

    CytoSorbents has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -27.1%. Mettler-Toledo International's return on equity of -- beat CytoSorbents's return on equity of -103.21%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    CTSO
    CytoSorbents
    52.3% -$0.04 $26.8M
  • What do Analysts Say About MTD or CTSO?

    Mettler-Toledo International has a consensus price target of $1,360.80, signalling upside risk potential of 16.06%. On the other hand CytoSorbents has an analysts' consensus of $5.00 which suggests that it could grow by 400%. Given that CytoSorbents has higher upside potential than Mettler-Toledo International, analysts believe CytoSorbents is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    CTSO
    CytoSorbents
    1 1 0
  • Is MTD or CTSO More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison CytoSorbents has a beta of 1.167, suggesting its more volatile than the S&P 500 by 16.732%.

  • Which is a Better Dividend Stock MTD or CTSO?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CytoSorbents offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. CytoSorbents pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or CTSO?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than CytoSorbents quarterly revenues of $8.6M. Mettler-Toledo International's net income of $252.3M is higher than CytoSorbents's net income of -$2.3M. Notably, Mettler-Toledo International's price-to-earnings ratio is 28.93x while CytoSorbents's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.45x versus 1.56x for CytoSorbents. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.45x 28.93x $1B $252.3M
    CTSO
    CytoSorbents
    1.56x -- $8.6M -$2.3M
  • Which has Higher Returns MTD or DCTH?

    Delcath Systems has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -22.5%. Mettler-Toledo International's return on equity of -- beat Delcath Systems's return on equity of -117.89%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DCTH
    Delcath Systems
    85.92% -$0.11 $68.7M
  • What do Analysts Say About MTD or DCTH?

    Mettler-Toledo International has a consensus price target of $1,360.80, signalling upside risk potential of 16.06%. On the other hand Delcath Systems has an analysts' consensus of $22.50 which suggests that it could grow by 73.34%. Given that Delcath Systems has higher upside potential than Mettler-Toledo International, analysts believe Delcath Systems is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    DCTH
    Delcath Systems
    4 0 0
  • Is MTD or DCTH More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Delcath Systems has a beta of 0.853, suggesting its less volatile than the S&P 500 by 14.729%.

  • Which is a Better Dividend Stock MTD or DCTH?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Delcath Systems offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Delcath Systems pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or DCTH?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Delcath Systems quarterly revenues of $15.1M. Mettler-Toledo International's net income of $252.3M is higher than Delcath Systems's net income of -$3.4M. Notably, Mettler-Toledo International's price-to-earnings ratio is 28.93x while Delcath Systems's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.45x versus 10.26x for Delcath Systems. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.45x 28.93x $1B $252.3M
    DCTH
    Delcath Systems
    10.26x -- $15.1M -$3.4M
  • Which has Higher Returns MTD or DGX?

    Quest Diagnostics has a net margin of 24.14% compared to Mettler-Toledo International's net margin of 8.47%. Mettler-Toledo International's return on equity of -- beat Quest Diagnostics's return on equity of 12.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    DGX
    Quest Diagnostics
    32.74% $1.95 $13.3B
  • What do Analysts Say About MTD or DGX?

    Mettler-Toledo International has a consensus price target of $1,360.80, signalling upside risk potential of 16.06%. On the other hand Quest Diagnostics has an analysts' consensus of $177.10 which suggests that it could grow by 5.44%. Given that Mettler-Toledo International has higher upside potential than Quest Diagnostics, analysts believe Mettler-Toledo International is more attractive than Quest Diagnostics.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    DGX
    Quest Diagnostics
    7 10 0
  • Is MTD or DGX More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Quest Diagnostics has a beta of 0.781, suggesting its less volatile than the S&P 500 by 21.91%.

  • Which is a Better Dividend Stock MTD or DGX?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quest Diagnostics offers a yield of 1.79% to investors and pays a quarterly dividend of $0.75 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Quest Diagnostics pays out 38% of its earnings as a dividend. Quest Diagnostics's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios MTD or DGX?

    Mettler-Toledo International quarterly revenues are $1B, which are smaller than Quest Diagnostics quarterly revenues of $2.6B. Mettler-Toledo International's net income of $252.3M is higher than Quest Diagnostics's net income of $222M. Notably, Mettler-Toledo International's price-to-earnings ratio is 28.93x while Quest Diagnostics's PE ratio is 21.84x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.45x versus 1.93x for Quest Diagnostics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.45x 28.93x $1B $252.3M
    DGX
    Quest Diagnostics
    1.93x 21.84x $2.6B $222M
  • Which has Higher Returns MTD or STRR?

    Star Equity Holdings has a net margin of 24.14% compared to Mettler-Toledo International's net margin of -14.37%. Mettler-Toledo International's return on equity of -- beat Star Equity Holdings's return on equity of -17.45%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    STRR
    Star Equity Holdings
    26.02% -$0.94 $65.7M
  • What do Analysts Say About MTD or STRR?

    Mettler-Toledo International has a consensus price target of $1,360.80, signalling upside risk potential of 16.06%. On the other hand Star Equity Holdings has an analysts' consensus of $10.00 which suggests that it could grow by 323.73%. Given that Star Equity Holdings has higher upside potential than Mettler-Toledo International, analysts believe Star Equity Holdings is more attractive than Mettler-Toledo International.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    STRR
    Star Equity Holdings
    1 0 0
  • Is MTD or STRR More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Star Equity Holdings has a beta of 0.668, suggesting its less volatile than the S&P 500 by 33.205%.

  • Which is a Better Dividend Stock MTD or STRR?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Star Equity Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Star Equity Holdings pays out -19.54% of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or STRR?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Star Equity Holdings quarterly revenues of $17.1M. Mettler-Toledo International's net income of $252.3M is higher than Star Equity Holdings's net income of -$2.5M. Notably, Mettler-Toledo International's price-to-earnings ratio is 28.93x while Star Equity Holdings's PE ratio is 0.75x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.45x versus 0.14x for Star Equity Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.45x 28.93x $1B $252.3M
    STRR
    Star Equity Holdings
    0.14x 0.75x $17.1M -$2.5M
  • Which has Higher Returns MTD or WAT?

    Waters has a net margin of 24.14% compared to Mettler-Toledo International's net margin of 26.52%. Mettler-Toledo International's return on equity of -- beat Waters's return on equity of 43.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    MTD
    Mettler-Toledo International
    61.17% $11.96 $1.9B
    WAT
    Waters
    60.07% $3.88 $3.5B
  • What do Analysts Say About MTD or WAT?

    Mettler-Toledo International has a consensus price target of $1,360.80, signalling upside risk potential of 16.06%. On the other hand Waters has an analysts' consensus of $404.35 which suggests that it could grow by 13.58%. Given that Mettler-Toledo International has higher upside potential than Waters, analysts believe Mettler-Toledo International is more attractive than Waters.

    Company Buy Ratings Hold Ratings Sell Ratings
    MTD
    Mettler-Toledo International
    2 11 1
    WAT
    Waters
    6 15 0
  • Is MTD or WAT More Risky?

    Mettler-Toledo International has a beta of 1.281, which suggesting that the stock is 28.096% more volatile than S&P 500. In comparison Waters has a beta of 1.036, suggesting its more volatile than the S&P 500 by 3.583%.

  • Which is a Better Dividend Stock MTD or WAT?

    Mettler-Toledo International has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Waters offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Mettler-Toledo International pays -- of its earnings as a dividend. Waters pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios MTD or WAT?

    Mettler-Toledo International quarterly revenues are $1B, which are larger than Waters quarterly revenues of $872.7M. Mettler-Toledo International's net income of $252.3M is higher than Waters's net income of $231.4M. Notably, Mettler-Toledo International's price-to-earnings ratio is 28.93x while Waters's PE ratio is 33.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Mettler-Toledo International is 6.45x versus 7.17x for Waters. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    MTD
    Mettler-Toledo International
    6.45x 28.93x $1B $252.3M
    WAT
    Waters
    7.17x 33.24x $872.7M $231.4M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Should I Buy Alcoa Stock?
Should I Buy Alcoa Stock?

Alcoa (AA) finds itself in an interesting position in early…

Where Will Nu Holdings Stock Be in 2030?
Where Will Nu Holdings Stock Be in 2030?

Despite fast growth, high profitability and an extraordinary runway ahead,…

Is it Too Late to Buy United Airlines Stock?
Is it Too Late to Buy United Airlines Stock?

United Airlines (NASDAQ:UAL) has thoroughly outpaced the broader stock market…

Stock Ideas

Buy
56
Is AAPL Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 37x

Sell
47
Is MSFT Stock a Buy?

Market Cap: $2.8T
P/E Ratio: 32x

Sell
44
Is NVDA Stock a Buy?

Market Cap: $2.7T
P/E Ratio: 38x

Alerts

Buy
54
NUTX alert for Apr 3

Nutex Health [NUTX] is up 5.41% over the past day.

Buy
52
PVH alert for Apr 3

PVH [PVH] is up 1.81% over the past day.

Sell
15
PCVX alert for Apr 3

Vaxcyte [PCVX] is up 4.47% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock